The Patent Finder
US

Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same

US 9,056,106 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Jul 20, 2032 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jul 14, 2010 as application 12/836,536 · Granted Jun 16, 2015
Base term plus 737 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2010 2032
Clock starts
Jul 14, 2010
Ends no later than
Jul 20, 2032
Granted
Jun 16, 2015
base term patent term adjustment fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
737
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 737 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 14, 2010, when this application, 12/836,536, was filedJul 14, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+737 days, USPTO patent term adjustment recordJul 20, 2032High confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Jul 20, 2032Medium confidence

This family

US 9,056,106this patent
no later than Jul 2032
no later than Jul 2032
Application 14/320,199Abandoned
not computed
not computed
Application 15/212,105Abandoned
not computed
not computed
US 10,765,726In force
Jun 2030
Jun 2030
Application 16/943,933Abandoned
not computed
not computed
Application 17/569,402Abandoned
not computed
not computed
Application 18/352,637Abandoned
not computed
not computed
Application 18/909,369Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Sep 21, 2010
Reel 25024, frame 354
Sinha, Uma; Lu, Genmin; Hutchaleelaha, Athiwat; Hollenbach, Stanley J.Portola Pharmaceuticals, Inc.Assignment of Assignor's Interest
Mar 18, 2019
Reel 48633, frame 673
Portola Pharmaceuticals, Inc.HCR Collateral Management, LLCSecurity Interest
Jul 2, 2020
Reel 53120, frame 925
HCR Collateral Management, LLCPortola Pharmaceuticals, Inc.Release of Security Interest
Jan 7, 2021
Reel 54920, frame 739
Portola Pharmaceuticals, Inc.Portola Pharmaceuticals, LLCChange of Name
Jan 7, 2021
Reel 54921, frame 131
Portola Pharmaceuticals, LLCAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 7, 2021
Reel 54922, frame 857
Alexion Pharma International Operations Unlimited CompanyAlexion Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jul 21, 2022
Reel 60799, frame 729
Alexion Pharmaceuticals, Inc.Alexion Pharma International Operations Unlimited CompanyAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited